| scholarly article | Q13442814 |
| P50 | author | Roman Junik | Q114328827 |
| P2093 | author name string | Joanna Kłubo-Gwieździńska | |
| P2860 | cites work | Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years | Q74059070 |
| Importance of lymph node metastases in follicular thyroid cancer | Q74231249 | ||
| Post-surgical ablation of thyroid remnants with high-dose (131)I in patients with differentiated thyroid carcinoma | Q74373300 | ||
| Papillary carcinoma of the thyroid gland: treatment based on risk group definition | Q77292834 | ||
| Positive predictive value of detectable stimulated tg during the first year after therapy of thyroid cancer and the value of comparison with Tg-ablation and Tg measured after 24 months | Q79378973 | ||
| Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma | Q81303709 | ||
| Thyroglobulin before ablation and correlation with posttreatment scanning | Q81358387 | ||
| Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients | Q81511216 | ||
| Outcome of ablation of thyroid remnants with 100 mCi (3.7 GBq) iodine-131 in patients with thyroid cancer | Q81894617 | ||
| A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. | Q34188774 | ||
| Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer | Q34215677 | ||
| Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients | Q34523261 | ||
| The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients | Q35790175 | ||
| Pre-ablative diagnostic whole-body scan following total thyroidectomy for well-differentiated thyroid cancer: is it necessary? | Q36106044 | ||
| Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer. | Q36245365 | ||
| 131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review | Q36619849 | ||
| Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study | Q38470389 | ||
| Prognostic factors and risk group analysis in follicular carcinoma of the thyroid | Q40377504 | ||
| Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas | Q40645167 | ||
| A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example | Q41505779 | ||
| Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. | Q43583286 | ||
| Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. | Q47386305 | ||
| The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma | Q48004293 | ||
| First treatment activity and outcome of radioiodine therapy in thyroid cancer patients with metastases in lymph nodes: mathematical correlation and clinical implications. | Q51943741 | ||
| Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy. | Q52933085 | ||
| Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. | Q53263951 | ||
| The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. | Q53356444 | ||
| Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas | Q56794015 | ||
| Recurrent Papillary Thyroid Cancer: Analysis of Prognostic Factors Including the Histological Variant | Q57584072 | ||
| Serum Thyroglobulin Levels at the Time of131I Remnant Ablation Just after Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients with Differentiated Thyroid Carcinoma | Q57762283 | ||
| Fractionated Dosage of Radioiodine for the Ablation of Differentiated Thyroid Carcinoma | Q63431036 | ||
| Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer | Q68191091 | ||
| Long-term results and prognostic factors in patients with differentiated thyroid carcinoma | Q70048752 | ||
| Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer | Q72849361 | ||
| Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer | Q72870335 | ||
| Thyroid carcinoma | Q72991392 | ||
| Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates | Q73322361 | ||
| Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma | Q73689158 | ||
| Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer | Q73883538 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | Polish | Q809 |
| P921 | main subject | differentiated thyroid carcinoma | Q56013722 |
| P304 | page(s) | 123-130 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Endokrynologia Polska | Q9253923 |
| P1476 | title | The early treatment results of well differentiated thyroid cancer and its dependence on chosen factors | |
| P478 | volume | 59 |
Search more.